Cargando…
Lack of adverse health effects following 30-weeks of dietary exposure to acrylamide at low doses in male F344 rats
Understanding the health hazards following exposure to food-borne acrylamide, especially at low levels typified by human diets, is an ongoing food safety issue. We recently published results from a study that aimed to understand the effects of acrylamide short-term exposure at doses known to cause t...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5616078/ https://www.ncbi.nlm.nih.gov/pubmed/28959591 http://dx.doi.org/10.1016/j.toxrep.2016.08.010 |
_version_ | 1783266718540365824 |
---|---|
author | Raju, Jayadev Kocmarek, Andrea Roberts, Jennifer Taylor, Marnie Patry, Dominique Chomyshyn, Emily Caldwell, Don Cooke, Gerard Mehta, Rekha |
author_facet | Raju, Jayadev Kocmarek, Andrea Roberts, Jennifer Taylor, Marnie Patry, Dominique Chomyshyn, Emily Caldwell, Don Cooke, Gerard Mehta, Rekha |
author_sort | Raju, Jayadev |
collection | PubMed |
description | Understanding the health hazards following exposure to food-borne acrylamide, especially at low levels typified by human diets, is an ongoing food safety issue. We recently published results from a study that aimed to understand the effects of acrylamide short-term exposure at doses known to cause tumors in rodents, demonstrating that a number of key toxicological end points were altered by acrylamide exposure. Additionally, we reported that at much lower doses for 30 weeks of exposure, dietary acrylamide was ‘not a complete carcinogen’ to the colon in an organ-specific rodent carcinogenesis study but acted as a co-carcinogen along with azoxymethane (AOM, a colon-specific carcinogen). Here, we present toxicological data from a sub-set of this long-term exposure study from animals that received saline (instead of AOM). Briefly, male F344 rats were randomized to receive acrylamide at 0.5, 1.0 and 2.0 mg/kg diet (∼0.02, 0.04, and 0.09 mg/kg BW/day, respectively) or no acrylamide (control), for 30 weeks; all rats were then euthanized and their tissues harvested and processed for toxicological evaluation. We report that at the doses tested, acrylamide did not cause any changes in general well-being, body weight or food intake. Similarly, acrylamide did not cause any biologically relevant change in parameters associated with immunophenotyping, serum biochemistry or hematology. Histopathology assessment of tissues showed no changes except in the testis, where non-specific mild lesions were observed in all the groups, inclusive of the controls. No neuropathological effects of acrylamide were observed in the brain and nerve tissues. Together, these results suggest that acrylamide administered to rats through the diet at low doses for 30 weeks did not cause any toxicologically relevant changes. Given that the doses of acrylamide in the current study are low and are comparable to human dietary exposure, this null-effect study provides data that contribute to the body of scientific evidence relevant to understanding the health effects of acrylamide. |
format | Online Article Text |
id | pubmed-5616078 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-56160782017-09-28 Lack of adverse health effects following 30-weeks of dietary exposure to acrylamide at low doses in male F344 rats Raju, Jayadev Kocmarek, Andrea Roberts, Jennifer Taylor, Marnie Patry, Dominique Chomyshyn, Emily Caldwell, Don Cooke, Gerard Mehta, Rekha Toxicol Rep Article Understanding the health hazards following exposure to food-borne acrylamide, especially at low levels typified by human diets, is an ongoing food safety issue. We recently published results from a study that aimed to understand the effects of acrylamide short-term exposure at doses known to cause tumors in rodents, demonstrating that a number of key toxicological end points were altered by acrylamide exposure. Additionally, we reported that at much lower doses for 30 weeks of exposure, dietary acrylamide was ‘not a complete carcinogen’ to the colon in an organ-specific rodent carcinogenesis study but acted as a co-carcinogen along with azoxymethane (AOM, a colon-specific carcinogen). Here, we present toxicological data from a sub-set of this long-term exposure study from animals that received saline (instead of AOM). Briefly, male F344 rats were randomized to receive acrylamide at 0.5, 1.0 and 2.0 mg/kg diet (∼0.02, 0.04, and 0.09 mg/kg BW/day, respectively) or no acrylamide (control), for 30 weeks; all rats were then euthanized and their tissues harvested and processed for toxicological evaluation. We report that at the doses tested, acrylamide did not cause any changes in general well-being, body weight or food intake. Similarly, acrylamide did not cause any biologically relevant change in parameters associated with immunophenotyping, serum biochemistry or hematology. Histopathology assessment of tissues showed no changes except in the testis, where non-specific mild lesions were observed in all the groups, inclusive of the controls. No neuropathological effects of acrylamide were observed in the brain and nerve tissues. Together, these results suggest that acrylamide administered to rats through the diet at low doses for 30 weeks did not cause any toxicologically relevant changes. Given that the doses of acrylamide in the current study are low and are comparable to human dietary exposure, this null-effect study provides data that contribute to the body of scientific evidence relevant to understanding the health effects of acrylamide. Elsevier 2016-08-31 /pmc/articles/PMC5616078/ /pubmed/28959591 http://dx.doi.org/10.1016/j.toxrep.2016.08.010 Text en Crown Copyright © 2016 Published by Elsevier Ireland Ltd. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Article Raju, Jayadev Kocmarek, Andrea Roberts, Jennifer Taylor, Marnie Patry, Dominique Chomyshyn, Emily Caldwell, Don Cooke, Gerard Mehta, Rekha Lack of adverse health effects following 30-weeks of dietary exposure to acrylamide at low doses in male F344 rats |
title | Lack of adverse health effects following 30-weeks of dietary exposure to acrylamide at low doses in male F344 rats |
title_full | Lack of adverse health effects following 30-weeks of dietary exposure to acrylamide at low doses in male F344 rats |
title_fullStr | Lack of adverse health effects following 30-weeks of dietary exposure to acrylamide at low doses in male F344 rats |
title_full_unstemmed | Lack of adverse health effects following 30-weeks of dietary exposure to acrylamide at low doses in male F344 rats |
title_short | Lack of adverse health effects following 30-weeks of dietary exposure to acrylamide at low doses in male F344 rats |
title_sort | lack of adverse health effects following 30-weeks of dietary exposure to acrylamide at low doses in male f344 rats |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5616078/ https://www.ncbi.nlm.nih.gov/pubmed/28959591 http://dx.doi.org/10.1016/j.toxrep.2016.08.010 |
work_keys_str_mv | AT rajujayadev lackofadversehealtheffectsfollowing30weeksofdietaryexposuretoacrylamideatlowdosesinmalef344rats AT kocmarekandrea lackofadversehealtheffectsfollowing30weeksofdietaryexposuretoacrylamideatlowdosesinmalef344rats AT robertsjennifer lackofadversehealtheffectsfollowing30weeksofdietaryexposuretoacrylamideatlowdosesinmalef344rats AT taylormarnie lackofadversehealtheffectsfollowing30weeksofdietaryexposuretoacrylamideatlowdosesinmalef344rats AT patrydominique lackofadversehealtheffectsfollowing30weeksofdietaryexposuretoacrylamideatlowdosesinmalef344rats AT chomyshynemily lackofadversehealtheffectsfollowing30weeksofdietaryexposuretoacrylamideatlowdosesinmalef344rats AT caldwelldon lackofadversehealtheffectsfollowing30weeksofdietaryexposuretoacrylamideatlowdosesinmalef344rats AT cookegerard lackofadversehealtheffectsfollowing30weeksofdietaryexposuretoacrylamideatlowdosesinmalef344rats AT mehtarekha lackofadversehealtheffectsfollowing30weeksofdietaryexposuretoacrylamideatlowdosesinmalef344rats |